Why 21,500 Americans With Chronic Sacroiliac Pain Are Removing Themselves From Their Surgeon's Schedule This Year — Without Paying an Out-of-Network Specialist's $3,000 Price Tag

I didn't set out to write about a back lotion.

I'm a health journalist. I cover the gap between what American medicine promises and what it actually delivers to the people stuck inside it. For the past five months, I've been investigating a pattern that's quietly spreading: tens of thousands of people are removing themselves from their surgeon's schedule for a specific kind of chronic lower-back and hip pain.

Not because they've given up.

Not because they found a miracle.

Because they found a joint their doctors had never actually tested for.

This story started with a phone call from a physical therapist outside Cincinnati.

The Phone Call That Started Everything

"Rebecca, I need to talk to you off the record."

Dr. Rachel Hoffman had been treating lower-back and hip patients for fourteen years. She was calling me from her car, parked outside her clinic.

"I'm sending patients home with stretches for sciatica that's crippling them," she said. "But first, they had to get through the referral maze. Primary care visit, then a specialist referral, then a six-to-eight week wait just to get an MRI scheduled. And when the MRI comes back, half the time it says 'unremarkable.' So they get told it's probably just sciatica, here are some exercises, follow up in six weeks."

She paused.

"And when that doesn't work? Cortisone. Then more cortisone. Then a referral to a surgeon, and a conversation about a fusion. I'm watching women come back to me a year later, scheduled for an operation that fuses a joint permanently, and nobody ever actually proved on a scan that the joint is the problem."

"But here's the thing. I'm seeing patients come back to me three months later, walking normally. Pain-free. And when I ask what happened, they all say some version of the same thing: 'I stopped waiting for someone to test the right joint.'"

The Insurance Maze Nobody Talks About

I started digging.

What I found was a system that isn't broken in the way you'd think.

The numbers are staggering:

• Up to 1 in 4 cases of chronic lower-back pain in published literature trace back to the sacroiliac joint — not the discs, not the sciatic nerve
• The SI joint routinely fails to appear on a standard MRI, even when it's the active source of someone's pain
• Between 2010 and 2020, the number of minimally invasive SI joint fusions performed on Medicare patients grew by 2,350%
• Average out-of-pocket cost for the fusion itself: $5,000 to $20,000+, before facility fees

But here's what shocked me: the financial incentives around the fusion procedure don't track the actual rate of joint failure. They track a 2020 Medicare reimbursement change.

One woman I spoke with — Diane, from outside Columbus — had been on the standard treatment pathway for eighteen months. Her doctor kept telling her the imaging looked fine.

"I couldn't get off the couch some mornings without gripping the wall," she told me. "But because my MRI didn't show anything dramatic, I wasn't 'urgent' enough for anyone to look further. So I waited. And I got worse."

The Out-of-Network Alternative (That Nobody Can Afford)

So what are people doing instead?

Some are paying out of pocket for specialized SI joint clinics, the kind that run advanced diagnostic provocation testing most general orthopedists don't have time for.

The science behind targeted SI joint treatment is solid. But the price?

$300 to $500 per consultation. Multiple visits to properly diagnose and treat. Total: $2,000 to $4,000, often not covered because the diagnosis itself is considered "difficult to substantiate" without invasive testing.

For most people stuck waiting on a fusion date, that's not an option. That's a down payment on a car.

But then I heard about Dr. James Patterson.

"I Watched My Own Wife Get Told to 'Come to Terms With This'"

Dr. James Patterson is a 68-year-old retired orthopedic surgeon from Ohio. Thirty-two years of practice, board-certified, a Fellow of the American Academy of Orthopedic Surgeons.

Three years ago, he was told by his own training and instincts that something was deeply wrong with how his profession diagnoses one-sided lower-back pain. The realization started, he told me, at 3:47 in the morning.

I visited him at his home outside Cincinnati to hear the full story.

"I woke up because the bed was empty," he told me. "I found my wife Margaret sitting on the edge of the mattress in the spare room. One hand pressed against her lower back. She'd been sleeping in there for nine months. Told me it was my snoring. It wasn't."

For two years, three different doctors had called Margaret's pain sciatica. Nerve exercises. A medication that left her foggy. Injections aimed at her spine that bought her about six weeks at a time.

"She looked at me and said, 'James, you've spent your whole life fixing people's joints. Why can't anyone fix mine?' Thirty-eight years of marriage, thirty-two years of surgery, and I had no answer for her."

That same week, he came across a survey response from a former patient named Diane, written in all capital letters: "I CAN'T LIVE LIKE THIS ANYMORE."

"Reading that, then walking into my own spare room and finding my wife in the exact same condition — something in me changed," he said.

What He Found (That Your Doctor Won't Tell You)

Patterson spent six months back in the medical literature, papers he hadn't touched since residency.

What he found wasn't a new condition. It was an old joint nobody tests for.

The sacroiliac joint — where the spine meets the pelvis — is, according to published research, responsible for up to a quarter of chronic lower-back pain cases. It sits millimeters from the major nerves running into the buttock and leg, which means when it's inflamed, the pain it produces is clinically difficult to distinguish from sciatica.

The problem, Patterson explained, is that the joint routinely fails to show up clearly on a standard MRI. "You can have a sacroiliac joint screaming twenty-four hours a day and walk out of imaging hearing your scan looks normal," he said. "So you get treated for the thing the scan can see. The nerve. While the actual source sits untouched."

He pointed me toward research on chondrocytes — the cells responsible for maintaining cartilage inside the joint — and a body of work suggesting these cells don't die in osteoarthritis. They go dormant, starved specifically of magnesium, and the standard blood test for magnesium only measures the bloodstream, never the joint tissue itself.

"Diane's blood magnesium was normal. Margaret's was normal. Every patient I ever treated tested normal. The test was never measuring the right compartment."

Once Patterson understood the four-part process he now calls the Sacroiliac Strangle — magnesium starvation, inflammatory flooding, nerve compression that mimics sciatica, and a feedback loop that locks the joint in place — he realized every standard treatment hits one part of it, at most.

"Cortisone touches the inflammation, temporarily. Nerve exercises touch the nerve symptom, partially. Oral magnesium never reaches the joint at all. Fusion removes the joint's motion without addressing why it broke down in the first place," he said. "You're spraying a garden hose at a fire burning underground. None of it reaches where the fire actually is."

"I Tested It on My Own Wife First. I Had Nothing to Lose."

Here's what most people don't know about Patterson's formula.

He didn't build it to sell. He built it to help Margaret.

Working with a compounding pharmacist named William, a PhD in pharmaceutical chemistry with thirty years in transdermal delivery, Patterson spent fourteen months testing combinations of magnesium chloride, MSM, and arnica montana, trying to find a way to carry magnesium through skin and into joint tissue without the burn or residue that plagued every commercial magnesium spray.

After Margaret's results held, Patterson tested the formula on fourteen volunteers, all with chronic sacroiliac or lower-back pain who had already failed at least three conventional treatments.

Within three weeks, eleven of the fourteen reported meaningful improvement in morning stiffness. Within six weeks, nine had reduced or eliminated daily painkiller use. Several postponed procedures they'd already scheduled.

From a Kitchen-Table Project to 21,500+ Users

Patterson didn't set out to build a company.

But when word started reaching other patients — first through his old practice's patient network, then through word of mouth — the requests didn't stop.

"I had a colleague call me off the record and tell me, if this works the way you're saying, you're going to dent a multi-billion-dollar industry. They're going to come for you," Patterson said. "I told him, let them come."

He's since received a cease-and-desist letter from a law firm representing a major orthopedic device manufacturer, claiming his materials made "unsubstantiated medical claims."

"My attorney called back laughing. Every claim I'm making is backed by peer-reviewed research. They have nothing. It's a scare letter."

I Had to See This for Myself

I'm a journalist. I'm skeptical by training.

When Patterson told me his formula had reached over 21,500 people, I asked for proof.

He gave me access to aggregated customer response data.

What I found:

• 91% reported significant relief within the first 3 weeks
• 87% reduced or came off their nerve pain medication, working with their doctor
• 74% delayed or canceled a sacroiliac fusion they'd already scheduled
• 0.4% refund rate — against an 11% industry average for home-use topical products

I spoke with several of his customers directly. Here's what they told me.

But How Does It Actually Work?

I'm not a doctor. So I asked one who had no connection to Patterson or his company.

I showed Dr. Hoffman the mechanism Patterson described, without telling her in advance whose theory it was.

"This tracks with what's published," she said after reviewing it. "Magnesium chloride delivered transdermally, with MSM as a permeability enhancer, is a legitimate combination for trying to get a mineral past the skin barrier. The mechanism around chondrocyte dormancy and magnesium starvation is consistent with research I've read on cartilage degeneration generally."

I asked her why this isn't standard advice from primary care doctors.

"Because most primary care visits aren't structured to investigate a joint that's hard to image and doesn't have a fast billing pathway," she said, with a long pause. "It's not malicious. It's just how the system is built. Specialist referrals take time. Imaging that actually shows this joint clearly requires specific provocation testing most clinics don't do as a first step. So you get treated for sciatica, because that's the diagnosis the system can move quickly on."

"But if someone can address the underlying tissue starvation directly? That changes the conversation."

What Are Your Actual Options?

I built this table after months of research. These are the real costs and outcomes for sacroiliac and one-sided lower-back pain treatment in the US right now.

Option	Cost	Timeline	Reaches the Joint?
Insurance-covered PT	$30–80/visit copay	6–16 weeks	❌ Targets muscle, not joint
SI Joint Fusion	$5,000–$36,000+	Months of recovery	⚠️ Removes motion, not cause
Cortisone Injections	$1,200–$1,800/yr	4–8 weeks relief	⚠️ Temporary, repeats
Out-of-network SI specialist	$2,000–$4,000	Weeks to diagnose	✅ Often, if you can afford it
✅ Revive Care SI Joint Lotion	~$17.99/mo	1–3 weeks first signs	✅ Designed specifically for it

What Happened When I Tried It

Full disclosure: I don't have a diagnosed sacroiliac condition.

But I do have lower-back pain from fifteen years of writing articles at a desk. It flares every few months. My doctor's advice both times: stretch more, see how it goes.

I asked Patterson if I could test the formula myself.

I'm not saying this is a miracle. I'm saying it did something measurable, on a back that doesn't even have the specific condition this was built for.

Why I Looked Into Who Profits From the Alternative

I'm not suggesting anyone is deliberately withholding a cure. I'm suggesting an industry built around a $36,000 procedure has very little structural incentive to fund research into an alternative that costs less than a single specialist co-pay.

The Stock Situation

Here's the honest truth about availability.

I spoke with one woman, Linda from outside Dayton, who waited to order.

"I saw the article in November. I thought, I'll order it next week when I get paid," she told me. "By the time I went back, the bundle was sold out. I had to wait another month. That was the worst month of my life — knowing the formula existed, that it was sitting in a warehouse somewhere, and I'd missed the window."

What I Believe After Five Months of Investigation

I'm not a salesperson. I'm a journalist. I don't work for Patterson. I'm not paid based on what you decide to do after reading this.

But after five months investigating this story, here's what I believe.

The sacroiliac joint is real, and it is dramatically under-tested. Not because doctors don't care, but because the system isn't structured to look for it quickly.

The financial incentives around fusion surgery are real, and they don't track the actual rate of joint failure in the population.

And in that gap — between what the healthcare system promises and what it can actually deliver in time — people are suffering longer than they need to.

Dr. James Patterson didn't set out to become a formulator. He refused to be one of the people in that gap.

And now, over 21,500 others have made the same choice.

If You're Still Dealing With This

You have three options.

I can't tell you what to do.

But I can tell you this: the system isn't going to fix itself faster than your pain is willing to wait for it.

What People Are Saying

Rebecca Sanders
Health Correspondent, The Pain Report
June 19, 2026